Clinical Trial Update: A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating pemetrexed in combination with cyclophosphamide every 21 days in patients with advanced breast cancer; the trial has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2009-07-16